Forum Report
Corporate Use of TIAA-CREF
“Ten Questions” for Shareholder Survey
For those of you interested in the December
meeting's Forum projects for either the use of investor surveys or the
development of a standard set questions about executive compensation, Amgen
is inviting its shareholders to offer comments on the TIAA-CREF “Ten
Questions.” The invitation is presented in the executive compensation
section of the company's proxy statement, directing shareholders to a
questionnaire on the corporate web site:
►
Amgen, Inc., Definitive Proxy
Statement, filed March 26, 2009
(110 pages, 894 KB, in
PDF
format); see bookmark for "Executive Compensation Website -
Stockholder Survey," on page 51 of proxy statement (PDF page 42)
►
Amgen, Inc., website survey
(5 pages, 73 KB, in
PDF
format)
It should be noted that Amgen's test of these processes is independent of
the Forum.
Your observations will be welcomed regarding this variation of the corporate
use of questions suggested in December (by a representative of a different
company). Comments will also be appreciated on the questions
themselves, or on possible alternative questions such as
those presented by RiskMetrics-ISS.
GL – April 1, 2009
Gary Lutin
Lutin & Company
575 Madison Avenue, 10th Floor
New York, New York 10022
Tel: 212-605-0335
Email:
gl@shareholderforum.com
|